IE890935L - Novel alkanophenones - Google Patents

Novel alkanophenones

Info

Publication number
IE890935L
IE890935L IE890935A IE93589A IE890935L IE 890935 L IE890935 L IE 890935L IE 890935 A IE890935 A IE 890935A IE 93589 A IE93589 A IE 93589A IE 890935 L IE890935 L IE 890935L
Authority
IE
Ireland
Prior art keywords
optionally
lower alkyl
salt
denotes
obtainable according
Prior art date
Application number
IE890935A
Other versions
IE66248B1 (en
Inventor
Von Andreas Sprecker
Andreas Beck
Original Assignee
Thomas Murray
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Murray filed Critical Thomas Murray
Publication of IE890935L publication Critical patent/IE890935L/en
Publication of IE66248B1 publication Critical patent/IE66248B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)

Abstract

Substituted alkanophenones of the general formula <IMAGE> in which R1 denotes optionally fluorinated lower alkyl, R2 represents hydrogen, optionally fluorinated lower alkyl or lower alkenyl, X denotes lower alkylene, oxy, thio or a direct bond, alk represents lower alkylene, n stands for 1 or 2, R3 denotes phenyl which is unsubstituted or substituted by optionally fluorinated lower alkyl, etherified or esterified hydroxyl, optionally lower alkylated amino and/or optionally esterified or amidated carboxyl or denotes lower alkyl which is optionally fluorinated or substituted by optionally esterified or amidated carboxyl, R4 represents optionally esterified or amidated carboxyl or 5-tetrazolyl and R5 stands for hydrogen or lower alkyl, have leukotriene-antagonist properties and can be used as antiallergic pharmaceutical active compounds. The process for their preparation is characterised in that an epoxide of the formula <IMAGE> in which R1, R2, X, alk, n and R3 have the above meanings, is reacted with a thiol of the formula <IMAGE> in which R4 and R5 have the above meanings, or a salt thereof and, if desired, a compound obtainable according to the process is converted into another compound of the formula I, a stereoisomer mixture obtainable according to the process is resolved into the components and/or a free compound obtainable according to the process is converted into a salt or a salt obtainable according to the process is converted into the free compound or into another salt. [EP0335315A1]
IE93589A 1988-03-29 1989-03-23 Novel alkanophenones IE66248B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH118688 1988-03-29
CH385788 1988-10-14

Publications (2)

Publication Number Publication Date
IE890935L true IE890935L (en) 1989-09-29
IE66248B1 IE66248B1 (en) 1995-12-27

Family

ID=25686932

Family Applications (1)

Application Number Title Priority Date Filing Date
IE93589A IE66248B1 (en) 1988-03-29 1989-03-23 Novel alkanophenones

Country Status (19)

Country Link
EP (1) EP0335315B1 (en)
JP (1) JP2777183B2 (en)
KR (1) KR0125933B1 (en)
AT (1) ATE107639T1 (en)
AU (1) AU623383B2 (en)
CA (1) CA1340463C (en)
CY (1) CY1967A (en)
DE (1) DE58907920D1 (en)
DK (1) DK148989A (en)
ES (1) ES2056137T3 (en)
FI (1) FI94342C (en)
HK (1) HK192696A (en)
HU (2) HU202852B (en)
IE (1) IE66248B1 (en)
IL (1) IL89713A0 (en)
NO (1) NO171555C (en)
NZ (1) NZ228477A (en)
PT (1) PT90125B (en)
YU (1) YU63089A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
AP791A (en) 1995-04-14 1999-12-17 Glaxo Wellcome Inc Metered dose inhaler for albuterol.
KR19980703850A (en) 1995-04-14 1998-12-05 그레이엄브레레톤 Weighing Aspirator for Beclomethasone Dipropionate
MX9707864A (en) * 1995-04-14 1997-11-29 Glaxo Wellcome Inc DOSE INHALER MEASURED BY SALMETEROL.
MX9707862A (en) 1995-04-14 1997-11-29 Glaxo Wellcome Inc DOSE INHALER MEASURED FOR FLUTICASONE PROPIONATE.
IT1320162B1 (en) 2000-02-09 2003-11-18 Rotta Research Lab DERIVATIVES OF THYROSIN WITH ANTI LEUKOTRIENIC ACTIVITY, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE.
US7019031B2 (en) 2000-10-23 2006-03-28 The Arizona Disease Control Research Commission Anticancer agents based on regulation of protein prenylation
JP4691988B2 (en) 2002-10-03 2011-06-01 小野薬品工業株式会社 LPA receptor antagonist
ATE528276T1 (en) * 2003-12-19 2011-10-15 Ono Pharmaceutical Co LYSOPHOSPHATIDYL ACID RECEPTOR ANTAGONIST COMPOUNDS AND THEIR APPLICATIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14579T1 (en) * 1979-03-20 1985-08-15 Fisons Plc PHARMACEUTICAL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
US4474788A (en) * 1981-11-12 1984-10-02 Fisons Plc Anti-SRSA quinoline carboxylic acid derivatives
AU548450B2 (en) * 1983-08-08 1985-12-12 G.D. Searle & Co. Substituted dihydrobenzopyrans
EP0147217A3 (en) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Leukotriene antagonists
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0419411A3 (en) * 1989-09-19 1991-09-04 Ciba-Geigy Ag Additional alkanophenones

Also Published As

Publication number Publication date
IE66248B1 (en) 1995-12-27
FI891362A7 (en) 1989-09-30
CY1967A (en) 1997-07-04
KR0125933B1 (en) 1997-12-26
YU63089A (en) 1990-12-31
DE58907920D1 (en) 1994-07-28
PT90125B (en) 1994-10-31
NZ228477A (en) 1990-11-27
JP2777183B2 (en) 1998-07-16
HU210531A9 (en) 1995-04-28
ATE107639T1 (en) 1994-07-15
DK148989D0 (en) 1989-03-28
DK148989A (en) 1989-09-30
PT90125A (en) 1989-11-10
CA1340463C (en) 1999-03-23
JPH01299283A (en) 1989-12-04
AU623383B2 (en) 1992-05-14
NO171555C (en) 1993-03-31
ES2056137T3 (en) 1994-10-01
NO891286L (en) 1989-10-02
IL89713A0 (en) 1989-09-28
NO171555B (en) 1992-12-21
FI94342C (en) 1995-08-25
FI891362A0 (en) 1989-03-22
HK192696A (en) 1996-10-25
KR890014511A (en) 1989-10-24
NO891286D0 (en) 1989-03-28
HU202852B (en) 1991-04-29
EP0335315B1 (en) 1994-06-22
EP0335315A1 (en) 1989-10-04
AU3225289A (en) 1989-10-12
HUT49599A (en) 1989-10-30
FI94342B (en) 1995-05-15

Similar Documents

Publication Publication Date Title
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
KR870001142A (en) Preparation of Phenyl Ether
KR900006318A (en) Piperidinyl Benzimidazole
CA2024381A1 (en) Xanthine compounds
IE870586L (en) Cyclodextrin clathrates of carbacyclin derivatives.
IE890935L (en) Novel alkanophenones
AU560980B2 (en) New vitro alphatic compounds
IL63782A (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles,their preparation and pharmaceutical compositions containing them
IL91620A0 (en) 4,5-diaryl-2-substituted thioimidazoles,their preparation and pharmaceutical compositions containing them
IE810232L (en) Phenyl hydroxyalkyl ethers and thioethers
AU562253B2 (en) Thiazolothienoazepine or pyridiue derivatives
DE3070768D1 (en) 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them
ES8501382A1 (en) Phenyl-acetic-acid derivatives, their preparation and pharmaceutical compostions containing them.
JPS5728077A (en) Novel dimethacrylic acid ester of dimethylol-tetrahydrofuran, manufacture and use as adhesive
GB2111056A (en) Derivatives of 1, 4-thiazane-carboxylic acid preparation and utilization thereof and compositions containing same
AU6823490A (en) New substituted amino acid derivatives, process for preparing these and pharmaceutical compositions containing them
HU895651D0 (en) Process for the preparation of substituted 3-amino-nonimine derivatives and pharmaceutical compositions containing said compounds
KR890009896A (en) Dioxazosine derivatives, their preparation and compositions containing them
AU557395B2 (en) Preparation of thieno-imidazole derivatives
AU2742288A (en) Novel compound effective as cerebral insufficiency improver
JPS54128583A (en) Thiosemicarbazone derivative
JPS5639074A (en) Pyrimidine derivative
IL84364A0 (en) 4-hydroxy-4-(substituted alkenyl)-cyclohexanecarboxylic acids,process for their preparation and pharmaceutical compositions containing same
JPS6426585A (en) Cis-3-chloro-4-silyloxy-2-cyclopenten-1-ols, production thereof and production of 3-chloro-4-silyloxy-2-cyclopenten-1-ones by using said compounds
KR830007520A (en) Preparation of Peptides

Legal Events

Date Code Title Description
MM4A Patent lapsed